news Cilcare establishes its Japan subsidiary as its springboard for Asia-Pacific growth Learn More > 29 September 2026 Cilcare & CBSET to bring ototoxicity assessment into focus at ACT 2026 Learn More > 17 September 2026 Cilcare appoints Dr. Louis Delamarre as Medical Director of Translational Research Learn More > 3 September 2026 Cilcare at IEB 2026: Advancing our understanding of hearing disorders Learn More > 1 September 2026 Cilcare Doubles Down on Hearing Loss: Updates License Deal with Sanofi who becomes equity holder Learn More > 23 June 2026 Backed by FEDER, Cilcare accelerates AI-driven hearing research and next-generation preclinical platforms Learn More > 26 May 2026 Camille Rochmann to Present at the 2026 Future of Hearing Healthcare Conference Learn More > 11 May 2026 Cilcare steps up its U.S. expansion: Clinical trial at MGH, threefold capacity growth with CBSET, and launch of a gateway for foreign biotechs entering the American market Learn More > 5 May 2026 Webinar Replay Now Online: Streamlining Ototoxicity Studies Learn More > 19 February 2026 « Previous Page1 Page2 Page3 … Page28 Next »
Cilcare establishes its Japan subsidiary as its springboard for Asia-Pacific growth Learn More > 29 September 2026
Cilcare & CBSET to bring ototoxicity assessment into focus at ACT 2026 Learn More > 17 September 2026
Cilcare appoints Dr. Louis Delamarre as Medical Director of Translational Research Learn More > 3 September 2026
Cilcare Doubles Down on Hearing Loss: Updates License Deal with Sanofi who becomes equity holder Learn More > 23 June 2026
Backed by FEDER, Cilcare accelerates AI-driven hearing research and next-generation preclinical platforms Learn More > 26 May 2026
Camille Rochmann to Present at the 2026 Future of Hearing Healthcare Conference Learn More > 11 May 2026
Cilcare steps up its U.S. expansion: Clinical trial at MGH, threefold capacity growth with CBSET, and launch of a gateway for foreign biotechs entering the American market Learn More > 5 May 2026
